Molecular identification of potential selective estrogen receptor modulator (SERM) like properties of phytoestrogens in the human breast cancer cell line MCF-7

被引:51
作者
Diel, P [1 ]
Olff, S [1 ]
Schmidt, S [1 ]
Michna, H [1 ]
机构
[1] Deutsch Sporthsch, Inst Morphol & Tumorforsch, D-50927 Cologne, Germany
关键词
SERM; coumestrol; daidzein; genistein; MCF-7; cell; phytoestrogen;
D O I
10.1055/s-2001-16474
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Numerous epidemiologic studies revealed that ethnic populations with higher dietary intake of phytoestrogens have the lowest incidence for breast cancer. The molecular mechanisms which may be responsible for this cancer protective action of phytoestrogens are so far only barely characterised. There are some hints that phytoestrogens may act like selective estrogen receptor modulators (SERMs) on the breast. For this reason we have investigated potential SERM-like properties of the phytoestrogens daidzein (Dal), coumestrol (Cou), and genistein (Gen) in the human breast cancer cell line MCF-7. Effects of these substances on progesterone (PR) and estrogen receptor alpha (ER) mRNA expression and estrogen receptor a protein levels were studied in comparison to estradiol (E2) and the synthetic SERMs raloxifene (Ral) and faslodex (ICI 182 780). PR mRNA expression was up-regulated after administration of Cou, whereas treatment with Dal and Gen induced only a faint increase. ER mRNA expression was down-regulated by Cou but not affected by Dal and Gen. The content of ER protein in the breast cancer cells was strongly decreased by Gen, only a faint reduction could be observed following administration of Cou, whereas administration of Dal slightly increases ER protein levels. In summary and in comparison to the effects observed after administration of E2, Rai, and ICI it turned out that Cou shows molecular properties which are very similar to an estrogen receptor agonist like E2, whereas the molecular properties of Gen are comparable to the SERMs ICI and Rai. These results clearly indicate that phytoestrogens differ significantly in regard to their molecular action on breast cancer cells and can be subdivided into distinct functional categories.
引用
收藏
页码:510 / 514
页数:5
相关论文
共 21 条
[1]   Epidemiology of phytoestrogens [J].
Adlercreutz, M .
BAILLIERES CLINICAL ENDOCRINOLOGY AND METABOLISM, 1998, 12 (04) :605-623
[2]   The selective estrogen receptor modulator, raloxifene: An overview of nonclinical pharmacology and reproductive and developmental testing [J].
Buelke-Sam, J ;
Bryant, HU ;
Francis, PC .
REPRODUCTIVE TOXICOLOGY, 1998, 12 (03) :217-221
[3]   ANTIESTROGEN ICI-164,384 REDUCES CELLULAR ESTROGEN-RECEPTOR CONTENT BY INCREASING ITS TURNOVER [J].
DAUVOIS, S ;
DANIELIAN, PS ;
WHITE, R ;
PARKER, MG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (09) :4037-4041
[4]   Antiestrogens - tamoxifen, SERMs and beyond [J].
Dhingra, K .
INVESTIGATIONAL NEW DRUGS, 1999, 17 (03) :285-311
[5]   The pure antiestrogen ICI 182780 is more effective in the induction of apoptosis and down regulation of BCL-2 than tamoxifen in MCF-7 cells [J].
Diel, P ;
Smolnikar, K ;
Michna, H .
BREAST CANCER RESEARCH AND TREATMENT, 1999, 58 (02) :87-97
[6]   In vitro test systems for the evaluation of the estrogenic activity of natural products [J].
Diel, P ;
Smolnikar, K ;
Michna, H .
PLANTA MEDICA, 1999, 65 (03) :197-203
[7]  
DOWSETT M, 1995, LANCET, V345, P8948
[8]   Genistein in the control of breast cancer cell growth: insights into the mechanism of action in vitro [J].
Fioravanti, L ;
Cappelletti, V ;
Miodini, P ;
Ronchi, E ;
Brivio, M ;
Di Fronzo, G .
CANCER LETTERS, 1998, 130 (1-2) :143-152
[9]   USE OF TAMOXIFEN FOR BREAST-CANCER - 28 YEARS LATER [J].
JAIYESIMI, IA ;
BUZDAR, AU ;
DECKER, DA ;
HORTOBAGYI, GN .
JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (02) :513-529
[10]   SHOULD CLINICIAN BE CONCERNED ABOUT THE CARCINOGENIC POTENTIAL OF TAMOXIFEN [J].
JORDAN, VC ;
MORROW, M .
EUROPEAN JOURNAL OF CANCER, 1994, 30A (11) :1714-1721